A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/14 (2006.01) C12N 5/0783 (2010.01) A61P 9/10 (2006.01)
Patent
CA 2575689
The present invention relates to a method of treating or preventing atherosclerosis comprising administering to a mammal in need of such a treatment a) an antigen which has been used to activate in vitro a Tri cell population originating from said mammal, and b) the TO cell population activated by said antigen, said TO cell population being obtained from a CD4+ T lymphocyte population of said mammal.
L'invention concerne un procédé permettant de traiter ou de prévenir l'athérosclérose, qui consiste à administrer à un mammifère nécessitant un tel traitement: a) un antigène qui a servi à activer in vitro une population de cellules Tr1 originaire dudit mammifère, et b) la population de cellules Tr1 activée par ledit antigène, ladite population de cellules Tr1 étant obtenue à partir d'une population de lymphocytes CD4+ T dudit mammifère.
Brun Valerie
Groux Herve
Mallat Ziad
Tedgui Alain
Institut National de La Sante Et de La Recherche Medicale (inser
Smart & Biggar
Txcell
LandOfFree
Tr1 cells for use in atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tr1 cells for use in atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tr1 cells for use in atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1535000